A prospective, observational, open-label, multicentre study to investigate the daily treatment practice of ranibizumab in patients with neovascular age-related macular degeneration

Efficacy of treatment with ranibizumab in patients with wet age-related macular degeneration in routine clinical care: data from the COMPASS health services research

(2014) Armin Wolf et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Safety of ranibizumab in routine clinical practice: 1-year retrospective pooled analysis of four European neovascular AMD registries within the LUMINOUS programme

(2013) Frank G Holz et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial

(2013) Usha Chakravarthy et al.   LANCET

Three-year results of visual outcome with disease activity-guided ranibizumab algorithm for the treatment of exudative age-related macular degeneration

(2012) Ceklic Lala et al.   ACTA OPHTHALMOLOGICA

Treatment patterns, visual acuity and quality-of-life outcomes of the WAVE study - A noninterventional study of ranibizumab treatment for neovascular age-related macular degeneration in Germany

(2012) Robert P. Finger et al.   ACTA OPHTHALMOLOGICA

Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration

(2012) Daniel F. Martin et al.   OPHTHALMOLOGY

CHANGES IN VISUAL ACUITY IN PATIENTS WITH WET AGE-RELATED MACULAR DEGENERATION TREATED WITH INTRAVITREAL RANIBIZUMAB IN DAILY CLINICAL PRACTICE

(2012) Salomon Y. Cohen et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

Results of flexible ranibizumab treatment in age-related macular degeneration and search for parameters with impact on outcome

(2011) Heinrich Gerding et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Safety and Efficacy of a Flexible Dosing Regimen of Ranibizumab in Neovascular Age-Related Macular Degeneration: The SUSTAIN Study

(2011) Frank G. Holz et al.   OPHTHALMOLOGY

Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-Related Macular Degeneration: PIER Study Year 2

(2010) Prema Abraham et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Comparison of two intravitreal ranibizumab treatment schedules for neovascular age-related macular degeneration

(2010) B. Gupta et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

NOVEL METHOD FOR ANALYZING SNELLEN VISUAL ACUITY MEASUREMENTS

(2010) Ninel Z Gregori et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

Effects of Ranibizumab in Patients with Subfoveal Choroidal Neovascularization Attributable to Age-related Macular Degeneration

(2009) Simon P. Rothenbuehler et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials

(2009) P Mitchell et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Ranibizumab for exudative age-related macular degeneration: 24-month outcomes from a single-centre institutional setting

(2009) G. Querques et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

A Phase IIIb Study to Evaluate the Safety of Ranibizumab in Subjects with Neovascular Age-related Macular Degeneration

(2009) David S. Boyer et al.   OPHTHALMOLOGY

Evaluation of Injection Frequency and Visual Acuity Outcomes for Ranibizumab Monotherapy in Exudative Age-related Macular Degeneration

(2009) Hajir Dadgostar et al.   OPHTHALMOLOGY

Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study

(2008) David M. Brown et al.   OPHTHALMOLOGY